Method for in vitro mass proliferation and culturing of vδ1 t cells without need for artificial antigen-presenting cells

WO2025220807A1PCT designated stage Publication Date: 2025-10-23BIO SOLUTION CO LTD
-1 Cites -1 Cited by

Patent Information

Application Number
PCT/KR2024/012099
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-04-15
Filing Date
2024-08-14
Publication Date
2025-10-23

Smart Images

  • Figure KR2024012099_23102025_PF_FP_ABST
    Figure KR2024012099_23102025_PF_FP_ABST
Patent Text Reader

Abstract

The present invention relates to a method for mass proliferation and culturing of Vδ1 T cells, Vδ1 T cells produced by the method, and a use thereof, the method comprising a step for activating lymphocytes from a biological sample containing the lymphocytes, a step for isolating Vδ1 T cells from the activated cell population, and a step for proliferating and culturing the isolated Vδ1 T cells by treating the isolated Vδ1 T cells with an anti-TCRVδ1 antibody. The method for mass proliferation and culturing according to the present invention makes it possible to produce Vδ1 T cells without artificial antigen-presenting cells, while maintaining an excellent proliferation rate and purity, and thus can be effectively used in related technical fields such as cancer treatment using Vδ1 T cells.
Need to check novelty before this filing date? Find Prior Art